GHP Aug 2017

GHP / August 2017 3 Welcome to the August edition of GHP magazine. In this edition, we learn more about how researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. Elsewhere, we take a glimpse at privately held company with Canadian and U.S. shareholders, Dealers Ingredients. Finding out more about the quality natural ingredients they have been supplying to leading food manufactures across Canada since 1976. Finally, we discover how performance across Scotland’s accident and emergency departments was above the 95% target during June this year. I hope you enjoy reading this informative issue. AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility. 4. News 8. kdm communications: Who Says Scientists Can’t Communicate Clearly? 10. All Natural: Dealers Ingredients 12. NOVA Probiotics: The Growing Global Probiotics Market 14. Tranquil Hearts Companion Care LLC: Going the next Extra Mile 16. Thousands of New Roles to Be Created in Mental Health Workforce Plan 18. The Association of the British Pharmaceutical Industry: Will Biosimilars Revolutionise the Future of Health? 20. Vascular Dynamics, Inc: The Treatment of Resistant Hypertension 22. Frost & Sullivan: Personalised and Regenerative Wound Care Adopting Innovative Technologies 24. GSK Montrose: New £44m Facility at GSK Montrose 26. VCA Animal Hospitals: Successful Clinical Study on New-to-Market Clavamox ® Chewable Antibiotic Tablets 28. Ascom: Optimising Care Communications and Responsiveness 30. Paula Milone-Nuzzo: Presidency of MGH Institute of Health Professions in Boston Contents Jessie Daykin, Editor Phone: +44 (0) 203 725 6842 Email: [email protected] Website: www.ghp-magazine.com